These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 27138177)
1. Disposition and Pharmacology of a GalNAc3-conjugated ASO Targeting Human Lipoprotein (a) in Mice. Yu RZ; Graham MJ; Post N; Riney S; Zanardi T; Hall S; Burkey J; Shemesh CS; Prakash TP; Seth PP; Swayze EE; Geary RS; Wang Y; Henry S Mol Ther Nucleic Acids; 2016 May; 5(5):e317. PubMed ID: 27138177 [TBL] [Abstract][Full Text] [Related]
2. Disposition and Pharmacokinetics of a GalNAc3-Conjugated Antisense Oligonucleotide Targeting Human Lipoprotein (a) in Monkeys. Yu RZ; Gunawan R; Post N; Zanardi T; Hall S; Burkey J; Kim TW; Graham MJ; Prakash TP; Seth PP; Swayze EE; Geary RS; Henry SP; Wang Y Nucleic Acid Ther; 2016 Dec; 26(6):372-380. PubMed ID: 27500733 [TBL] [Abstract][Full Text] [Related]
3. Safety, Pharmacokinetic, and Pharmacodynamic Evaluation of a 2'-(2-Methoxyethyl)-D-ribose Antisense Oligonucleotide-Triantenarry Zanardi TA; Korbmacher B; Boone L; Engelhardt JA; Wang Y; Burel S; Prill B; Aghajan M; Guo S; Henry SP J Pharmacol Exp Ther; 2021 Apr; 377(1):51-63. PubMed ID: 33431610 [TBL] [Abstract][Full Text] [Related]
5. Integrated Assessment of the Clinical Performance of GalNAc Crooke ST; Baker BF; Xia S; Yu RZ; Viney NJ; Wang Y; Tsimikas S; Geary RS Nucleic Acid Ther; 2019 Feb; 29(1):16-32. PubMed ID: 30570431 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and Clinical Pharmacology Considerations of GalNAc Wang Y; Yu RZ; Henry S; Geary RS Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):475-485. PubMed ID: 31144994 [No Abstract] [Full Text] [Related]
7. Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice. Prakash TP; Graham MJ; Yu J; Carty R; Low A; Chappell A; Schmidt K; Zhao C; Aghajan M; Murray HF; Riney S; Booten SL; Murray SF; Gaus H; Crosby J; Lima WF; Guo S; Monia BP; Swayze EE; Seth PP Nucleic Acids Res; 2014 Jul; 42(13):8796-807. PubMed ID: 24992960 [TBL] [Abstract][Full Text] [Related]
8. Interspecies Scaling of Human Clearance and Plasma Trough Exposure for Antisense Oligonucleotides: A Retrospective Analysis of GalNAc3-Conjugated and Unconjugated-Antisense Oligonucleotides. Nanavati C; McMullen G; Yu R; Geary RS; Henry SP; Wang Y Nucleic Acid Ther; 2021 Aug; 31(4):298-308. PubMed ID: 33891483 [TBL] [Abstract][Full Text] [Related]
10. Elucidation of the Biotransformation Pathways of a Galnac3-conjugated Antisense Oligonucleotide in Rats and Monkeys. Shemesh CS; Yu RZ; Gaus HJ; Greenlee S; Post N; Schmidt K; Migawa MT; Seth PP; Zanardi TA; Prakash TP; Swayze EE; Henry SP; Wang Y Mol Ther Nucleic Acids; 2016 May; 5(5):e319. PubMed ID: 27164023 [TBL] [Abstract][Full Text] [Related]
11. Assessment of the Drug Interaction Potential of Unconjugated and GalNAc Shemesh CS; Yu RZ; Warren MS; Liu M; Jahic M; Nichols B; Post N; Lin S; Norris DA; Hurh E; Huang J; Watanabe T; Henry SP; Wang Y Mol Ther Nucleic Acids; 2017 Dec; 9():34-47. PubMed ID: 29246313 [TBL] [Abstract][Full Text] [Related]
12. Comparative Characterization of Hepatic Distribution and mRNA Reduction of Antisense Oligonucleotides Conjugated with Triantennary N-Acetyl Galactosamine and Lipophilic Ligands Targeting Apolipoprotein B. Watanabe A; Nakajima M; Kasuya T; Onishi R; Kitade N; Mayumi K; Ikehara T; Kugimiya A J Pharmacol Exp Ther; 2016 May; 357(2):320-30. PubMed ID: 26907624 [TBL] [Abstract][Full Text] [Related]
13. Cross-species pharmacokinetic comparison from mouse to man of a second-generation antisense oligonucleotide, ISIS 301012, targeting human apolipoprotein B-100. Yu RZ; Kim TW; Hong A; Watanabe TA; Gaus HJ; Geary RS Drug Metab Dispos; 2007 Mar; 35(3):460-8. PubMed ID: 17172312 [TBL] [Abstract][Full Text] [Related]
14. Cross-species comparison of in vivo PK/PD relationships for second-generation antisense oligonucleotides targeting apolipoprotein B-100. Yu RZ; Lemonidis KM; Graham MJ; Matson JE; Crooke RM; Tribble DL; Wedel MK; Levin AA; Geary RS Biochem Pharmacol; 2009 Mar; 77(5):910-9. PubMed ID: 19056355 [TBL] [Abstract][Full Text] [Related]